# ct-gov
Grab clinical trials associated with list of conditions.

Data source: ClinicalTrials.gov
All information returned is attributable to the clinicaltrials.gov website.

Input: semi-colon separated list of conditions via argparse (example below)
Output: Python dictionary (cout) with all trials from clinicaltrials.gov associated with the input condition

E.g. (queries run on 05/24/2018 -- data used as an example and is likely not current)
$python ct_crawler.py "Doose syndrome;Dravet syndrome;CLN2 Disease"
Doose syndrome {0: {'trial_number': ' NCT01533506', 'status': 'No longer available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01533506?cond=Doose+syndrome&amp;rank=1', 'title': 'Stiripentol in Dravet Syndrome'}, 1: {'trial_number': ' NCT02896608', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02896608?cond=Doose+syndrome&amp;rank=2', 'title': 'Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome'}, 2: {'trial_number': ' NCT01835314', 'status': 'Available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01835314?cond=Doose+syndrome&amp;rank=3', 'title': 'Compassionate Use of Stiripentol in Dravet Syndrome'}, 3: {'trial_number': ' NCT03299842', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03299842?cond=Doose+syndrome&amp;rank=4', 'title': 'A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome'}, 4: {'trial_number': ' NCT02826863', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02826863?cond=Doose+syndrome&amp;rank=5', 'title': 'A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome'}, 5: {'trial_number': ' NCT01983722', 'status': 'Available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01983722?cond=Doose+syndrome&amp;rank=6', 'title': 'Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome'}, 6: {'trial_number': ' NCT02823145', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02823145?cond=Doose+syndrome&amp;rank=7', 'title': 'An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome'}, 7: {'trial_number': ' NCT01607073', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01607073?cond=Doose+syndrome&amp;rank=8', 'title': 'Verapamil as Therapy for Children and Young Adults With Dravet Syndrome'}, 8: {'trial_number': ' NCT02318563', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02318563?cond=Doose+syndrome&amp;rank=9', 'title': 'Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome'}, 9: {'trial_number': ' NCT02174094', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02174094?cond=Doose+syndrome&amp;rank=10', 'title': 'Clobazam as Adjunctive Therapy in Paediatric Patients Aged &#8805;1 to &#8804;16 Years With Dravet Syndrome'}, 10: {'trial_number': ' NCT02187809', 'status': 'Terminated', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02187809?cond=Doose+syndrome&amp;rank=11', 'title': 'Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged &#8805;1 to &#8804;16 Years With Dravet Syndrome'}, 11: {'trial_number': ' NCT02926898', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02926898?cond=Doose+syndrome&amp;rank=12', 'title': 'A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children &#8805;2 Years Old and Young Adults With Dravet Syndrome'}, 12: {'trial_number': ' NCT02239276', 'status': 'Available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02239276?cond=Doose+syndrome&amp;rank=13', 'title': 'Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies'}, 13: {'trial_number': ' NCT02682927', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02682927?cond=Doose+syndrome&amp;rank=14', 'title': 'A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome'}, 14: {'trial_number': ' NCT02224703', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02224703?cond=Doose+syndrome&amp;rank=15', 'title': 'GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome'}, 15: {'trial_number': ' NCT02091375', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02091375?cond=Doose+syndrome&amp;rank=16', 'title': 'Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)'}, 16: {'trial_number': ' NCT02091206', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02091206?cond=Doose+syndrome&amp;rank=17', 'title': 'A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)'}, 17: {'trial_number': ' NCT03467113', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03467113?cond=Doose+syndrome&amp;rank=18', 'title': 'A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With DS or LGS Currently Taking CBD'}, 18: {'trial_number': ' NCT02229032', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02229032?cond=Doose+syndrome&amp;rank=19', 'title': 'Genetic Analysis Between Charlotte&apos;s Web Responders Versus Non- Responders in a Dravet Population'}, 19: {'trial_number': ' NCT02415686', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02415686?cond=Doose+syndrome&amp;rank=20', 'title': 'Cardiac Arrhythmias in Dravet Syndrome'}, 20: {'trial_number': ' NCT02910297', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02910297?cond=Doose+syndrome&amp;rank=21', 'title': 'The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy'}, 21: {'trial_number': ' NCT02758626', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02758626?cond=Doose+syndrome&amp;rank=22', 'title': 'Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome'}, 22: {'trial_number': ' NCT02815540', 'status': 'Not yet recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02815540?cond=Doose+syndrome&amp;rank=23', 'title': 'The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy'}, 23: {'trial_number': ' NCT02224573', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02224573?cond=Doose+syndrome&amp;rank=24', 'title': 'GWPCARE5 - An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes'}, 24: {'trial_number': ' NCT03254680', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03254680?cond=Doose+syndrome&amp;rank=25', 'title': 'Turmeric as Treatment in Epilepsy'}, 25: {'trial_number': ' NCT01858285', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01858285?cond=Doose+syndrome&amp;rank=26', 'title': 'Genetics of Severe Early Onset Epilepsies'}, 26: {'trial_number': ' NCT02318602', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02318602?cond=Doose+syndrome&amp;rank=27', 'title': 'Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder'}, 27: {'trial_number': ' NCT03024827', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03024827?cond=Doose+syndrome&amp;rank=28', 'title': 'Cannabidiol in Children With Refractory Epileptic Encephalopathy'}, 28: {'trial_number': ' NCT02286986', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02286986?cond=Doose+syndrome&amp;rank=29', 'title': 'Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy'}}
Dravet syndrome {0: {'trial_number': ' NCT02896608', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02896608?cond=Dravet+syndrome&amp;rank=1', 'title': 'Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome'}, 1: {'trial_number': ' NCT03299842', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03299842?cond=Dravet+syndrome&amp;rank=2', 'title': 'A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome'}, 2: {'trial_number': ' NCT01533506', 'status': 'No longer available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01533506?cond=Dravet+syndrome&amp;rank=3', 'title': 'Stiripentol in Dravet Syndrome'}, 3: {'trial_number': ' NCT01835314', 'status': 'Available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01835314?cond=Dravet+syndrome&amp;rank=4', 'title': 'Compassionate Use of Stiripentol in Dravet Syndrome'}, 4: {'trial_number': ' NCT02826863', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02826863?cond=Dravet+syndrome&amp;rank=5', 'title': 'A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome'}, 5: {'trial_number': ' NCT02823145', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02823145?cond=Dravet+syndrome&amp;rank=6', 'title': 'An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome'}, 6: {'trial_number': ' NCT01983722', 'status': 'Available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01983722?cond=Dravet+syndrome&amp;rank=7', 'title': 'Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome'}, 7: {'trial_number': ' NCT02926898', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02926898?cond=Dravet+syndrome&amp;rank=8', 'title': 'A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children &#8805;2 Years Old and Young Adults With Dravet Syndrome'}, 8: {'trial_number': ' NCT02318563', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02318563?cond=Dravet+syndrome&amp;rank=9', 'title': 'Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome'}, 9: {'trial_number': ' NCT02174094', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02174094?cond=Dravet+syndrome&amp;rank=10', 'title': 'Clobazam as Adjunctive Therapy in Paediatric Patients Aged &#8805;1 to &#8804;16 Years With Dravet Syndrome'}, 10: {'trial_number': ' NCT01607073', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01607073?cond=Dravet+syndrome&amp;rank=11', 'title': 'Verapamil as Therapy for Children and Young Adults With Dravet Syndrome'}, 11: {'trial_number': ' NCT02187809', 'status': 'Terminated', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02187809?cond=Dravet+syndrome&amp;rank=12', 'title': 'Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged &#8805;1 to &#8804;16 Years With Dravet Syndrome'}, 12: {'trial_number': ' NCT02239276', 'status': 'Available', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02239276?cond=Dravet+syndrome&amp;rank=13', 'title': 'Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies'}, 13: {'trial_number': ' NCT02682927', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02682927?cond=Dravet+syndrome&amp;rank=14', 'title': 'A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome'}, 14: {'trial_number': ' NCT02224703', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02224703?cond=Dravet+syndrome&amp;rank=15', 'title': 'GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome'}, 15: {'trial_number': ' NCT02091375', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02091375?cond=Dravet+syndrome&amp;rank=16', 'title': 'Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)'}, 16: {'trial_number': ' NCT02091206', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02091206?cond=Dravet+syndrome&amp;rank=17', 'title': 'A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)'}, 17: {'trial_number': ' NCT03467113', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03467113?cond=Dravet+syndrome&amp;rank=18', 'title': 'A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With DS or LGS Currently Taking CBD'}, 18: {'trial_number': ' NCT02229032', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02229032?cond=Dravet+syndrome&amp;rank=19', 'title': 'Genetic Analysis Between Charlotte&apos;s Web Responders Versus Non- Responders in a Dravet Population'}, 19: {'trial_number': ' NCT02415686', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02415686?cond=Dravet+syndrome&amp;rank=20', 'title': 'Cardiac Arrhythmias in Dravet Syndrome'}, 20: {'trial_number': ' NCT02910297', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02910297?cond=Dravet+syndrome&amp;rank=21', 'title': 'The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy'}, 21: {'trial_number': ' NCT02758626', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02758626?cond=Dravet+syndrome&amp;rank=22', 'title': 'Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome'}, 22: {'trial_number': ' NCT02815540', 'status': 'Not yet recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02815540?cond=Dravet+syndrome&amp;rank=23', 'title': 'The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy'}, 23: {'trial_number': ' NCT02224573', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02224573?cond=Dravet+syndrome&amp;rank=24', 'title': 'GWPCARE5 - An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes'}, 24: {'trial_number': ' NCT03254680', 'status': 'Withdrawn', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03254680?cond=Dravet+syndrome&amp;rank=25', 'title': 'Turmeric as Treatment in Epilepsy'}, 25: {'trial_number': ' NCT01858285', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01858285?cond=Dravet+syndrome&amp;rank=26', 'title': 'Genetics of Severe Early Onset Epilepsies'}, 26: {'trial_number': ' NCT02318602', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02318602?cond=Dravet+syndrome&amp;rank=27', 'title': 'Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder'}, 27: {'trial_number': ' NCT02286986', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02286986?cond=Dravet+syndrome&amp;rank=28', 'title': 'Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy'}, 28: {'trial_number': ' NCT03024827', 'status': 'Recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT03024827?cond=Dravet+syndrome&amp;rank=29', 'title': 'Cannabidiol in Children With Refractory Epileptic Encephalopathy'}}
CLN2 Disease {0: {'trial_number': ' NCT02963350', 'status': 'Approved for marketing', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02963350?cond=CLN2+Disease&amp;rank=1', 'title': 'A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease'}, 1: {'trial_number': ' NCT02485899', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02485899?cond=CLN2+Disease&amp;rank=2', 'title': 'A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease'}, 2: {'trial_number': ' NCT02678689', 'status': 'Enrolling by invitation', 'url': 'https://clinicaltrials.gov/ct2/show/NCT02678689?cond=CLN2+Disease&amp;rank=3', 'title': 'A Safety, Tolerability, and Efficacy Study of Intracerebroventricular BMN 190 in Pediatric Patients &lt; 18 Years of Age With CLN2 Disease'}, 3: {'trial_number': ' NCT01907087', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01907087?cond=CLN2+Disease&amp;rank=4', 'title': 'A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease'}, 4: {'trial_number': ' NCT01414985', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01414985?cond=CLN2+Disease&amp;rank=5', 'title': 'AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis'}, 5: {'trial_number': ' NCT00151216', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT00151216?cond=CLN2+Disease&amp;rank=6', 'title': 'Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis'}, 6: {'trial_number': ' NCT01161576', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01161576?cond=CLN2+Disease&amp;rank=7', 'title': 'Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)'}, 7: {'trial_number': ' NCT01035424', 'status': 'Active, not recruiting', 'url': 'https://clinicaltrials.gov/ct2/show/NCT01035424?cond=CLN2+Disease&amp;rank=8', 'title': 'Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis'}, 8: {'trial_number': ' NCT00151268', 'status': 'Completed', 'url': 'https://clinicaltrials.gov/ct2/show/NCT00151268?cond=CLN2+Disease&amp;rank=9', 'title': 'Genotype - Phenotype Correlations of LINCL'}}
